Nutrition and Food Sciences Department, National Research Centre, El-Bohouth St. (Tahrir St.Prev.), Dokki, 12622, Cairo, Egypt.
Environmental and Occupational Medicine Department, National Research Centre, El-Bohouth St. (Tahrir St.Prev.), Dokki, 12622, Cairo, Egypt.
Mol Biol Rep. 2022 Jun;49(6):5153-5163. doi: 10.1007/s11033-022-07226-2. Epub 2022 Feb 15.
The coronavirus disease (COVID-19) is caused by the severe acute syndrome coronavirus-2 (SARS-COV-2) and still threatens human life. This pandemic is still causing increased mortality throughout the world. Many recent studies have been conducted to discover the pathophysiology of this virus.
However, in this narrative review, we attempted to summarize some of the alterations in physiological pathways that were evident in this viral invasion. Excessive inflammation that progresses to cytokine storm, changes in humoral and cell-mediated immunity, and observed alterations in iron metabolism are included in the pathogenesis of the virus. Iron homeostasis disturbances may persist for more than two months after the onset of COVID-19, which may lead to reduced iron bioavailability, hypoferremia, hyperferritinemia, impaired hemoglobin, and red blood cell synthesis. Furthermore, hypoferriemia may impair immune system function. Until now, the traditional treatments discovered are still being tried.
However, using probiotics as an adjuvant was shown to have beneficial effects on both iron homeostasis and immunity in COVID-19. Herein, we discussed the possible mechanisms achieved by probiotics to ameliorate iron and immunity changes based on the available literature.
We concluded that supplementing probiotics with conventional therapy may improve COVID-19 symptoms and outcomes. Taking into consideration the use of good quality probiotics and appropriate dosage, undesirable effects can be avoided.
由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的冠状病毒病(COVID-19)仍然威胁着人类的生命。这种大流行仍在全球范围内导致死亡率上升。最近进行了许多研究以发现该病毒的病理生理学。
然而,在本叙述性综述中,我们试图总结该病毒入侵中明显存在的一些生理途径改变。发病机制包括过度炎症进展为细胞因子风暴、体液和细胞介导免疫的变化以及观察到的铁代谢改变。COVID-19 发病后,铁稳态紊乱可能持续超过两个月,这可能导致铁生物利用度降低、低血症、高铁蛋白血症、血红蛋白和红细胞合成受损。此外,低血症可能会损害免疫系统功能。到目前为止,发现的传统治疗方法仍在尝试中。
然而,作为辅助疗法使用益生菌已被证明对 COVID-19 中的铁稳态和免疫有有益作用。在此,我们根据现有文献讨论了益生菌通过哪些可能的机制来改善铁和免疫变化。
我们得出结论,在常规治疗的基础上补充益生菌可能会改善 COVID-19 症状和结果。考虑到使用高质量的益生菌和适当的剂量,可以避免不良影响。